Major trial shows breast cancer drug can hit prostate cancer Achilles heel 28 Apr 2020 A drug already licensed for the treatment of breast and ovarian cancers is more effective than targeted hormone therapy at keeping cancer in check in some men with advanced prostate cancer, a major clinical trial reports. Find out more Show/Hide
ICR research showcased in major new Science Museum gallery documenting history of medicine 29 Jan 2020 The Science Museum's new £24 million medicine galleries showcases pioneering research from The Institute of Cancer Research, London, as part of its story of modern medicine. Find out more Show/Hide
Scientists identify potential drug target for BRCA-mutated tumours 19 Dec 2019 A new study has uncovered a previously unknown role for the enzyme EXD2, identifying it as a potential drug target for cancer therapy. Find out more Show/Hide
ASCO 2019: Breast cancer drug effective in 80 per cent of men with BRCA-mutant prostate cancer 05 Jun 2019
The ICR responds to the FDA approval of talazoparib for women with BRCA-mutant advanced breast cancer 18 Oct 2018
The ICR responds to the FDA approval of olaparib for women with BRCA-mutant advanced breast cancer 12 Jan 2018